In a move that expresses healthcare providers’ frustration with generics pricing and allegations of price gouging, a consortium of hospitals in the USA have hit on a radical solution - starting their own pharmaceuticals company.
The New York Times reports that five organizations, representing over 450 hospitals, have joined forces to start the company with the intention of “helping patients by addressing the often unwarranted shortages and high costs of lifesaving generic medications."
The venture is led by Intermountain Healthcare, together with Ascension, SSM Health and Trinity Health, and in consultation with the US Department of Veterans Affairs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze